Michel Dreano
Founder bei Remedys Foundation
Profil
Michel Dreano is the founder of Sonnet BioTherapeutics CH SA and Remedys Foundation.
Prior to this, he worked as CFO, Director & Chief Business Officer at RELIEF THERAPEUTICS Holding SA from 2017 to 2019 and as a Manager-Project & Alliance at Serono International SA. Dr. Dreano holds a doctorate degree from L'Université de Bourgogne and Université Paris Diderot-Paris 7.
Aktive Positionen von Michel Dreano
Unternehmen | Position | Beginn |
---|---|---|
Remedys Foundation | Founder | - |
Ehemalige bekannte Positionen von Michel Dreano
Unternehmen | Position | Ende |
---|---|---|
RELIEF THERAPEUTICS HOLDING SA | Director of Finance/CFO | 26.04.2019 |
Serono International SA | Corporate Officer/Principal | - |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Founder | - |
Ausbildung von Michel Dreano
L'Université de Bourgogne | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
RELIEF THERAPEUTICS HOLDING SA | Health Technology |
Private Unternehmen | 4 |
---|---|
Université Paris Diderot-Paris 7 | Consumer Services |
Serono International SA | |
Sonnet BioTherapeutics CH SA
Sonnet BioTherapeutics CH SA Pharmaceuticals: MajorHealth Technology Sonnet BioTherapeutics CH SA develops cure for peripheral neuropathies. The company was founded by Michel Dreano and Gael Hédou in 2013 and is headquartered in Geneve, Switzerland. | Health Technology |
Remedys Foundation |